Have your own idea? Try our Stock Screener
Hong Kong (HSI) Pharma Industry Analysis
UpdatedApr 04, 2026
DataAggregated Company Financials
Companies43
- 7D9.5%
- 3M3.8%
- 1Y46.6%
- YTD3.8%
Over the last 7 days, the Pharma industry has risen 15%, driven by gains from Hansoh Pharmaceutical Group of 21%. In the same time, Xuanzhu Biopharmaceutical was down 12%. This takes the industry's 12 month performance to a gain of 47%. Looking forward, earnings are forecast to grow by 16% annually.
Industry Valuation and Performance
Has the Hong Kong Pharma Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 04 Apr 2026 | HK$808.6b | HK$513.1b | HK$29.8b | 15.4x | 27.2x | 1.6x |
| Mon, 02 Mar 2026 | HK$798.4b | HK$501.2b | HK$30.7b | 13.2x | 26x | 1.6x |
| Wed, 28 Jan 2026 | HK$828.7b | HK$493.2b | HK$30.2b | 13.3x | 27.4x | 1.7x |
| Fri, 26 Dec 2025 | HK$798.8b | HK$487.9b | HK$29.9b | 13.3x | 26.7x | 1.6x |
| Sun, 23 Nov 2025 | HK$788.3b | HK$481.9b | HK$29.9b | 13.2x | 26.3x | 1.6x |
| Tue, 21 Oct 2025 | HK$791.2b | HK$480.0b | HK$30.1b | 13.5x | 26.2x | 1.6x |
| Thu, 18 Sep 2025 | HK$810.7b | HK$480.3b | HK$30.7b | 14.2x | 26.4x | 1.7x |
| Sat, 16 Aug 2025 | HK$801.9b | HK$473.9b | HK$28.9b | 11.9x | 27.7x | 1.7x |
| Mon, 14 Jul 2025 | HK$661.3b | HK$476.0b | HK$29.1b | 11.4x | 22.7x | 1.4x |
| Wed, 11 Jun 2025 | HK$645.7b | HK$476.4b | HK$28.7b | 11.9x | 22.5x | 1.4x |
| Fri, 09 May 2025 | HK$505.4b | HK$470.8b | HK$28.8b | 10.6x | 17.6x | 1.1x |
| Sun, 06 Apr 2025 | HK$502.6b | HK$468.3b | HK$28.7b | 10.1x | 17.5x | 1.1x |
| Tue, 04 Mar 2025 | HK$432.6b | HK$461.1b | HK$31.7b | 8.4x | 13.6x | 0.9x |
| Thu, 30 Jan 2025 | HK$410.5b | HK$464.6b | HK$32.0b | 8.5x | 12.8x | 0.9x |
| Sat, 28 Dec 2024 | HK$435.6b | HK$459.8b | HK$31.7b | 8.6x | 13.7x | 0.9x |
| Mon, 25 Nov 2024 | HK$433.0b | HK$462.9b | HK$31.5b | 8x | 13.7x | 0.9x |
| Wed, 23 Oct 2024 | HK$486.2b | HK$471.1b | HK$32.7b | 7.9x | 14.9x | 1x |
| Fri, 20 Sep 2024 | HK$436.8b | HK$475.9b | HK$33.0b | 7.5x | 13.2x | 0.9x |
| Sun, 18 Aug 2024 | HK$455.1b | HK$463.8b | HK$32.2b | 8.3x | 14.1x | 1x |
| Tue, 16 Jul 2024 | HK$424.6b | HK$458.1b | HK$32.5b | 7.4x | 13.1x | 0.9x |
| Thu, 13 Jun 2024 | HK$464.8b | HK$463.2b | HK$33.9b | 8.4x | 13.7x | 1x |
| Sat, 11 May 2024 | HK$491.4b | HK$464.2b | HK$33.8b | 8.7x | 14.5x | 1.1x |
| Mon, 08 Apr 2024 | HK$440.9b | HK$465.1b | HK$36.5b | 7.2x | 12.1x | 0.9x |
| Wed, 06 Mar 2024 | HK$436.1b | HK$470.6b | HK$33.5b | 8x | 13x | 0.9x |
| Fri, 02 Feb 2024 | HK$404.7b | HK$471.7b | HK$33.7b | 7x | 12x | 0.9x |
| Sun, 31 Dec 2023 | HK$495.2b | HK$473.5b | HK$33.9b | 7.7x | 14.6x | 1x |
| Tue, 28 Nov 2023 | HK$509.8b | HK$472.3b | HK$32.3b | 7.3x | 15.8x | 1.1x |
| Thu, 26 Oct 2023 | HK$437.7b | HK$469.0b | HK$31.5b | 6.7x | 13.9x | 0.9x |
| Sat, 23 Sep 2023 | HK$427.5b | HK$469.2b | HK$31.5b | 6.8x | 13.6x | 0.9x |
| Mon, 21 Aug 2023 | HK$423.3b | HK$446.0b | HK$28.2b | 9.3x | 15x | 0.9x |
| Wed, 19 Jul 2023 | HK$476.5b | HK$446.7b | HK$27.9b | 9.3x | 17.1x | 1.1x |
| Fri, 16 Jun 2023 | HK$509.7b | HK$446.9b | HK$27.7b | 9.5x | 18.4x | 1.1x |
| Sun, 14 May 2023 | HK$539.6b | HK$452.3b | HK$28.3b | 9x | 19x | 1.2x |
| Tue, 11 Apr 2023 | HK$545.0b | HK$453.8b | HK$28.8b | 9.4x | 18.9x | 1.2x |
Price to Earnings Ratio
18.9x
Current Industry PE
- Investors are optimistic on the Hong Kong Pharmaceuticals industry, and appear confident in long term growth rates.
- The industry is trading at a PE ratio of 27.4x which is higher than its 3-year average PE of 17.9x.
- The 3-year average PS ratio of 1.2x is lower than the industry's current PS ratio of 1.6x.
Past Earnings Growth
- The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 4.1% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 0.96% | |
| Healthcare | 6.83% | |
| Pharma | 9.55% | |
| Pharma | 9.55% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 3692 Hansoh Pharmaceutical Group | HK$39.36 | 20.9% +HK$41.2b | 66.1% | PE37.7x | |
| 1177 Sino Biopharmaceutical | HK$6.33 | 7.5% +HK$7.8b | 62.7% | PE42.4x | |
| 1093 CSPC Pharmaceutical Group | HK$9.71 | 4.5% +HK$4.8b | 75.6% | PE25.1x | |
| 2096 Simcere Pharmaceutical Group | HK$13.62 | 12.8% +HK$4.0b | 57.3% | PE23x | |
| 3320 China Resources Pharmaceutical Group | HK$6.27 | 11.2% +HK$4.0b | 20.3% | PE8.6x |